ACVC Premium Access

Dilemmas in anti thrombotic therapy

Event: Acute Cardiovascular Care 2016
Topic: Antithrombotic agents
Session type: Symposium
Date: 16 October 2016
Time: 11:00 - 12:30

Congress Session

4 presentations in this session

New tools to manage bleeding under NOACS.

Speaker: Professor K. Huber (Vienna, AT)

To pre treat or not to pre treat in ACS?

Speaker: Associate Professor S. Matetzky (Ramat Gan, IL)

Anti thrombotic choices after bleeding.

Speaker: Professor S. Halvorsen (Oslo, NO)

Optimal duration of dual antiplatelet therapy study after ACS.

Speaker: Professor J. Morais (Leiria, PT)

4 speakers from this session

Professor Kurt Huber

Wilhelminen Hospital, Vienna (Austria)
40 presentations

Associate Professor Shlomi Matetzky

Sheba Medical Center, Ramat Gan (Israel)
1 presentation
0 follower

Professor Sigrun Halvorsen

Oslo University Hospital Ulleval, Oslo (Norway)
20 presentations
0 follower

Professor Joao Morais

Leiria Hospital Centre, Leiria (Portugal)
13 presentations
0 follower

This platform is supported by

logo Novo Nordisk